We shown that, in contrast to classical opioid receptors, ACKR3 will not cause classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, which include morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Rather, we established that LIH383, an ACKR3-selective subnanomolar https://richardp600zbv1.blog5star.com/profile